Current through Register Vol. 63, No. 9, September 1, 2024
(1) At a
minimum, programs must ensure each of the following:
(a) Sufficient medical treatment staff
staffing with the ability to transfer or admit patients to ASAM Level 3.7-WM
program or a hospital as necessary;
(b) A LMP must be available daily for onsite
evaluation of patients;
(c) A LMP
must be available for phone consultation with staff 24 hours a day, 7 days per
week; and
(d) Medical treatment
staff, onsite and readily available 24 hours a day, 7 days per week, that are
trained and competent to:
(A) Facilitate entry
into withdrawal management services;
(B) Recognize the signs and symptoms of
intoxication and withdrawal;
(C)
Administer medical treatment;
(D)
Monitor conditions;
(E) Implement
LMP-approved protocols for patient; and
(F) Facilitate the transfer of patients to
other ASAM Levels of Care.
(2) Medications must be administered in
accordance with physician or LMP orders, or nursing orders that are in
accordance with LMP orders.
(3) The
medical assessment and examination must:
(a)
Contain a complete physical examination and a thorough comprehensive health
history, which includes review of behavioral and physical health diagnoses, a
description of behavior problems, prior evaluations, treatment history and a
review of current use of prescription and over-the-counter
medications.
(b) Be completed by a
LMP within 24 hours of entry for each patient in ASAM Level 3.7-WM programs;
or
(c) By a medical treatment staff
within 24 hours of entry for each patient in ASAM Level 3.2-WM programs;
and
(d) Documentation must include:
(A) The ASAM Level of Care placement
determination utilizing ASAM Dimensions 1, 2 and 3;
(B) Use of the ASAM dimensional admission
criteria and documentation that demonstrates the patient meets ASAM 3.7-WM
level of care by justifying the patient is:
(i) Experiencing severe intoxication or
withdrawal and needs 24-hour nursing care and daily access to a LMP;
(ii) In addition, may be experiencing severe
risk in Dimensions 2 and 3; and
(iii) Unlikely to complete withdrawal
management without medical monitoring.
(C) A conclusion that the withdrawal syndrome
can be safely managed at the ASAM Level of care placed;
(D) A recommended length of stay;
(E) Medication orders;
(F) Current protocols; and
(G) Identification of the patient's medical
needs relevant to stabilization.
(4) A medical stabilization plan must be
informed by the medical assessment and:
(a) Be
completed by a medical treatment staff;
(b) Identify initial orders for the
stabilization of each identified substance for withdrawal;
(c) Identify criteria for meeting safe
completion of medical protocols for acute withdrawal management services per
substance being treated, including the recommended length of
services;
(d) Note the extent of
the patient's participation in developing the content of the stabilization
plan;
(e) Document any
modifications; and
(f) The
inclusion or notification of significant others in the stabilization planning
process, when applicable.
(5) The following information must be
recorded in the patient's service record at the time of admission:
(a) Name, address, and telephone
number;
(b) Contact information for
individual to contact in case of an emergency or unplanned exit of services,
when a corresponding release of information, compliant with 42 CFR part 2 and
HIPAA, is also on file and valid;
(c) Identification of patient's family and
social support, if any;
(d) The
time and date of admission;
(e) The
name and credentials of program staff completing the admission
documentation;
(f) Documentation of
the patient's ability to evacuate the home consistent with the program's
evacuation plan developed in accordance with the Oregon Structural Specialty
Code and Oregon Fire Code;
(g)
Documentation of any safety risks;
(h) Documentation of follow-up actions and
referrals when an patient reports symptoms indicating risk of suicide;
and
(i) When medical services are
provided, the following documents must be part of the Service Record as
applicable:
(A) Medication administration
records as per these rules;
(B)
Laboratory reports; and
(C) LMP
orders for medication, protocols or procedures.
(6) At the time of transition from withdrawal
management services, a medical stabilization summary must be completed by
medical treatment staff. The medical stabilization summary must contain:
(a) Final evaluation of the patient's
progress toward stabilization for each of the substances treated;
(b) Identification of any unresolved
withdrawal symptoms;
(c) List of
medications prescribed for continuation following the transition; and
(d) Where applicable, a medical opinion of
the patient's capacity to resolve the identified issue(s) due to any known or
observed cause, such as a co-occurring behavioral or medical
condition.
Statutory/Other Authority: ORS
413.042 & ORS
430.256
Statutes/Other Implemented: ORS
430.306 & ORS
430.345-430.375